Adenovirus-mediated expression of pig α(1, 3) galactosyltransferase reconstructs Gal a(1, 3) Gal epitope on the surface of human tumor cells
Open Access
- 1 June 2001
- journal article
- research article
- Published by Springer Nature in Cell Research
- Vol. 11 (2) , 116-124
- https://doi.org/10.1038/sj.cr.7290076
Abstract
Gal α(1, 3) Gal (gal epitope) is a carbohydrate epitope and synthesized in large amount by α(1, 3) galactosyltransferase [α(1, 3) GT] enzyme on the cells of lower mammalian animals such as pigs and mice. Human has no gal epitope due to the inactivation of α(1, 3) GT gene but produces a large amount of antibodies (anti-Gal) which recognize Gal α(1, 3) Gal structures specifically. In this study, a replication-deficient recombinant adenoviral vector Ad5sGT containing pig α(1, 3) GT cDNA was constructed and characterized. Adenoviral vector-mediated transfer of pig α(1, 3) GT gene into human tumor cells such as malignant melanoma A375, stomach cancer SGC-7901, and lung cancer SPC-A-1 was reported for the first time. Results showed that Gal epitope did not increase the sensitivity of human tumor cells to human complement-mediated lysis, although human complement activation and the binding of human IgG and IgM natural antibodies to human tumor cells were enhanced significantly after Ad5sGT transduction. Appearance of gal epitope on the human tumor cells changed the expression of cell surface carbohydrates reacting with Ulex europaeus I (UEA I) lectins, Vicia villosa agglutinin (VVA), Arachis hypogaea agglutinin (PNA), and Glycine max agglutinin (SBA) to different degrees. In addition, no effect of gal epitope on the growth in vitro of human tumor cells was observed in MTT assay.Keywords
This publication has 14 references indexed in Scilit:
- Xenotransplantation: how to overcome the complement obstacle?Molecular Immunology, 1999
- Development and application of adenoviral vectors for gene therapy of cancerCancer Gene Therapy, 1999
- Xenoantigens and xenoantibodiesXenotransplantation, 1998
- Combined transgenic expression of α-galactosidase and α1,2-fucosyltransferase leads to optimal reduction in the major xenoepitope Galα(1,3)GalProceedings of the National Academy of Sciences, 1997
- DOWN-REGULATION OF Gal??(1,3)Gal EXPRESSION BY ??1,2-FUCOSYLTRANSFERASETransplantation, 1997
- Reduction in the level of Gal(alpha1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase.Proceedings of the National Academy of Sciences, 1996
- Sensitization of cells and retroviruses to human serum by (αl-3) galactosyltransferaseNature, 1996
- Molecular cloning, sequence, and expression of a human GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase cDNA that can form the H blood group antigen.Proceedings of the National Academy of Sciences, 1990
- A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5Virology, 1988
- Subcellular organization of glycosylation in mammalian cellsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1987